Safety and efficacy of acamprosate for the treatment of alcohol dependence [0.03%]
卡马普罗塞治疗酒精依赖有效性的安全性和疗效分析
Stephanie L Yahn,Lucas R Watterson,M Foster Olive
Stephanie L Yahn
Acamprosate (calcium acetylhomotaurine) is an amino acid modulator that has displayed efficacy in some clinical trials in reducing craving and promoting abstinence in alcohol dependent patients following detoxification. While acamprosate is...
All might have won, but not all have the prize: optimal treatment for substance abuse among adolescents with conduct problems [0.03%]
皆大欢喜，但奖品有限：青少年违纪行为伴随的药物滥用的最佳治疗方案
Jayson Spas,Susan Ramsey,Andrea L Paiva et al.
Jayson Spas et al.
Considerable evidence from the literature on treatment outcomes indicates that substance abuse treatment among adolescents with conduct problems varies widely. Treatments commonly used among this population are cognitive-behavioral therapy ...
Are you Sleeping? Pilot Comparison of Self-Reported and Objective Measures of Sleep Quality and Duration in an Inpatient Alcoholism Treatment Program [0.03%]
你在睡觉吗？住院酒精治疗项目中自我报告与客观测量的睡眠质量和数量对比研究
Alyssa T Brooks,Michael C Krumlauf,Barbara P Whiting et al.
Alyssa T Brooks et al.
Sleep disturbances are common among alcohol-dependent individuals and can increase risk of relapse. The current study compares subjective and objective measures of sleep quality and duration and describes the prevalence of baseline sleep di...
Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management [0.03%]
慢性阿片类药物理依赖的流行病学和分子病理生理及缓释纳曲酮制剂在临床上的应用位置分析
Albert Stuart Reece
Albert Stuart Reece
Naltrexone implants and depot injections (NI) are a novel form of treatment for opiate dependence (OD). Major questions relate to their absolute and relative efficacy and safety. Opportunely, six recent clinical trial data from several cont...
Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk score [0.03%]
使用汇总遗传风险评分对戒酒不足一年的酒精依赖性吸烟者进行安非他酮伐瘾试验中复发因素的研究：初步结果
John E McGeary,Valerie S Knopik,John E Hayes et al.
John E McGeary et al.
Introduction: Rates of smoking in the US population have decreased overall, but rates in some groups, including alcoholic smokers, remain high. Many newly sober alcoholics are concerned about their smoking and some attemp...
When research meets reality-lessons learned from a pragmatic multisite group-randomized clinical trial on psychosocial interventions in the psychiatric and addiction field [0.03%]
当研究遇到现实——精神疾病和成瘾领域务实多中心群随机临床试验的启示与教训
Linda E Wüsthoff,Helge Waal,Rolf W Gråwe
Linda E Wüsthoff
Research on treatments for patients with co-occurring psychiatric and substance use disorders is of core importance and at the same time highly challenging as it includes patients that are normally excluded from clinical studies. Such resea...
Development and Initial Validation of a Client-Rated MET-CBT Adherence Measure [0.03%]
MET-CBT依从性量表的编制及初步验证研究
Wendy R Ulaszek,Hsiu-Ju Lin,Linda K Frisman et al.
Wendy R Ulaszek et al.
Traditional mechanisms for rating adherence or fidelity are labor-intensive. We developed and validated a tool to rate adherence to Motivational Enhancement Therapy-Cognitive Behavioral Treatment (MET-CBT) through anonymous client surveys. ...
Monitoring Utilization of a Large Scale Addiction Treatment System: The Drug and Alcohol Treatment Information System (DATIS) [0.03%]
大型药物治疗系统的利用监测：药物和酒精治疗信息系统(DATIS)
Nooshin Khobzi Rotondi,Brian Rush
Nooshin Khobzi Rotondi
Client-based information systems can yield data to address issues of system accountability and planning, and contribute information related to changing patterns of substance use in treatment and, indirectly, general populations. The Drug an...
Bupropion reduces some of the symptoms of marihuana withdrawal in chronic marihuana users: a pilot study [0.03%]
安非他酮可减轻慢性大麻使用者的大麻戒断症状：一项初步研究
David M Penetar,Alison R Looby,Elizabeth T Ryan et al.
David M Penetar et al.
Bupropion's (Zyban(®) SR) effectiveness to treat symptoms experienced in marihuana withdrawal was tested in a double-blind, placebo-controlled study with chronic, heavy marihuana users. Participants maintained their usual marihuana intake ...
Tiffany A Brown,Pamela K Keel
Tiffany A Brown
Eating disorders are a significant source of psychiatric morbidity in young women and demonstrate high comorbidity with mood, anxiety, and substance use disorders. Thus, clinicians may encounter eating disorders in the context of treating o...